Literature DB >> 23091361

Dermal ultrastructure in low Beighton score members of 17 families with hypermobile-type Ehlers-Danlos syndrome.

Trinh Hermanns-Lê1, Marie-Annick Reginster, Claudine Piérard-Franchimont, Philippe Delvenne, Gérald E Piérard, Daniel Manicourt.   

Abstract

The distinction between the Ehlers-Danlos syndrome hypermobile type (EDSH) and the benign joint hypermobility syndrome (BJHS) is unclear. The aim of the present study was to compare skin ultrastructural abnormalities of EDSH and BJHS among different families. Skin of 23 EDSH, 27 BJHS, and 41 asymptomatic subjects from 17 families was examined using transmission electron microscopy. Similar ultrastructural abnormalities were found irrespective of the Beighton score. Flower-like collagen fibrils represented the key change and elastic fibers were altered as well. Beighton score is a clinical parameter rating joint mobility that appeared unrelated to quantitative and qualitative collagen ultrastructural alterations in the skin. Some EDSH family members fit with BJHS diagnosis. BJHS possibly represents a mild variant of EDSH.

Entities:  

Mesh:

Year:  2012        PMID: 23091361      PMCID: PMC3471064          DOI: 10.1155/2012/878107

Source DB:  PubMed          Journal:  J Biomed Biotechnol        ISSN: 1110-7243


1. Introduction

Ehlers-Danlos syndrome (EDS) is a cluster of inherited connective tissue disorders, mainly characterized by skin hyperextensibility, joint hyperlaxity, and tissue fragility. Both the classical and hypermobile (EDSH) EDS types are recognized as the most frequent presentations [1]. The prevalence of EDSH is estimated to range from 1/5,000 to 1/20,000. The major diagnostic criteria for EDSH are joint hypermobility associated with skin hyperextensibility and/or velvety aspect [2]. Recurrent joint dislocations, chronic joint/limb pain, and positive family history are considered as minor diagnostic criteria. Of note, joint laxity is common in healthy children under 5 years of age and appears to be related to gender and race [3-5]. Women usually show more extensive joint laxity than men. African, Asian, and Middle Eastern people present a similar physiological feature [6, 7]. Abnormal joint mobility is conveniently assessed using the Beighton scale. A score reaching 5/9 or above defines EDSH. Type III collagen [8] and tenascin-X [9] were reported to be mutated, but molecular abnormalities remain often undisclosed. By contrast, dermal ultrastructural features are commonly indicative [10-12]. Joint laxity is further present in the benign joint hypermobile syndrome (BJHS) [5] identified using the Brighton criteria [13]. The Beighton score must reach at least 4, and arthralgia be present in 4 or more joints for more than 3 months. Minor criteria combine a lower Beighton score and subluxation in more than one joint or in a single joint on more than one occasion as well as skin hyperextensibility and abnormal scarring. According to these definitions, the diagnostic criteria of EDSH and BJHS overlap. Accordingly, EDSH and BJHS are considered to be the same disorder by some authors [11, 14–17]. The aim of the present work was to revisit ultrastructural features in the skin of EDSH patients and their family members showing a lower Beighton score and/or with BJHS criteria.

2. Methods

A total of 91 consecutive patients, aged 9–62 years, from 17 families were explored using transmission electron microscopy. They were referred to rheumatology departments for familial joint hyperextensibility. Clinical assessments and skin biopsies were performed with the consent of the patients or the parents of minors. A total of 23 patients (20 women and 3 men) from the 17 families had a provisional diagnosis of EDSH according to the Villefranche nosology [1], and 68 other members of these 17 families presented with a Beighton score 4/9 or lower. A total of 27/68 subjects (18 men and 9 women) suffered from BJHS as defined by the Brighton criteria. Skin samples were prepared for transmission electron microscopy. They were immersed in 4% glutaraldehyde in a phosphate buffer at pH 7.4, postfixed in 1% osmium tetroxide, and embedded in epon. The ultrathin sections were double-stained with uranyl acetate and lead citrate. Observations were made under a Zeiss EM910 electron microscope operated at 60 kV. The diagnostic criteria were previously discussed [10, 12].

3. Results

The study started April 2008 until September 2011. The majority 65/91 of the skin samples (Table 1) showed flower-like collagen fibrils (FCF) in the papillary and/or reticular dermis (Figure 1). FCF were observed in all patients with EDSH and BJHS diagnosis, and in 15 apparently asymptomatic subjects as well. No gender influence was disclosed in the ultrastructural changes. The FCF numbers varied and appeared unrelated to the Beighton score. Other abnormalities of the connective tissue extracellular matrix (ECM) consisted of variable collagen fibril diameters, twisted collagen fibrils, irregular interfibrillar spacing, and granulofilamentous deposits inside the collagen bundles as well as whirled or disorganized bundles. The elastic fiber changes consisted of frayed contours, increased osmiophilic structures even in young subjects, and inclusions of calcified (Figure 2) or uncalcified microcavities. Large stellate globules of superposed hyaluronic acid (Figure 3) and focal granulofilamentous deposits were disclosed in the interstitial ECM.
Table 1

Frequency of finding flower-like collagen fibrils (FCF) in patients with Ehlers-Danlos syndrome hypermobile (EDSH) and in patients with the benign joint hypermobility syndrome (BJHS).

Disease statusNumber of patientsNumber of cases with FCF
EDSH2323
BJHS2727
Unaffected4115
Figure 1

Flower-like collagen fibrils (▸) and irregular interfibrillar spaces.

Figure 2

Calcified microcyst in an elastic fiber.

Figure 3

Globules of presumably hyaluronic acid and granulofilamentous meshwork inside the collagen bundles.

Intrafamilial dermal changes generally looked similar. In a 3/17 families, dermal changes were found in both parents. A total of 26 asymptomatic subjects of these families exhibited normal ultrastructural dermal features.

4. Discussion

Subjects with a Beighton score lower than 5/9 were not clinically considered as EDS. However, they showed dermal abnormalities including FCF as described earlier [10–12, 18]. In addition, ultrastructural ECM abnormalities were presently found in asymptomatic or low Beighton score subjects of EDS family pedigrees. These subjects possibly presented a subclinical EDS, or their joint hyperlaxity had possibly vanished with ageing and/or arthrosis. The presence of the dermal abnormalities was consistent with the genetic transmission of EDS morphological features from asymptomatic parents to their children. According to the Brighton criteria, 27 of the EDS family members fitted with BJHS diagnosis, and their dermal ECM showed typical EDS ultrastructural abnormalities. Accordingly, we support the concept that BJHS represents a mild variant of EDSH [14-17]. In spite of the relatively unspecific ultrastructural criteria of EDS, the global architecture and the ultrastructure of the dermal ECM are of diagnostic relevance, and they occasionally suggest a specific EDS type. For instance, abundant granulofilamentous deposits are found in subjects with mutations in the gene coding for tenascin-X. For these reasons, ultrastructural examination of the dermis is potentially helpful for confirming the diagnosis of EDS, and for disclosing some family members carrying the ECM alterations. The defects in collagen fibril formation are likely multiple suggesting variable penetrance.
  18 in total

Review 1.  Heritable disorders of connective tissue.

Authors:  R Grahame
Journal:  Baillieres Best Pract Res Clin Rheumatol       Date:  2000-06       Impact factor: 4.098

2.  The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS).

Authors:  R Grahame; H A Bird; A Child
Journal:  J Rheumatol       Date:  2000-07       Impact factor: 4.666

Review 3.  Joint hypermobility and genetic collagen disorders: are they related?

Authors:  R Grahame
Journal:  Arch Dis Child       Date:  1999-02       Impact factor: 3.791

4.  Hypermobility syndrome.

Authors:  D B Everman; N H Robin
Journal:  Pediatr Rev       Date:  1998-04

5.  Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Ehlers-Danlos National Foundation (USA) and Ehlers-Danlos Support Group (UK).

Authors:  P Beighton; A De Paepe; B Steinmann; P Tsipouras; R J Wenstrup
Journal:  Am J Med Genet       Date:  1998-04-28

6.  High prevalence of joint laxity in West Africans.

Authors:  F N Birrell; A O Adebajo; B L Hazleman; A J Silman
Journal:  Br J Rheumatol       Date:  1994-01

7.  Joint mobility among university students in Iraq.

Authors:  Z S Al-Rawi; A J Al-Aszawi; T Al-Chalabi
Journal:  Br J Rheumatol       Date:  1985-11

8.  Mechanical properties of skin in Ehlers-Danlos syndrome, types I, II, and III.

Authors:  F Henry; V Goffin; C Piérard-Franchimont; G E Piérard
Journal:  Pediatr Dermatol       Date:  1996 Nov-Dec       Impact factor: 1.588

9.  Differential ultrastructural aberrations of collagen fibrils in Ehlers-Danlos syndrome types I-IV as a means of diagnostics and classification.

Authors:  I Hausser; I Anton-Lamprecht
Journal:  Hum Genet       Date:  1994-04       Impact factor: 4.132

10.  A family with Ehlers-Danlos syndrome type III/articular hypermobility syndrome has a glycine 637 to serine substitution in type III collagen.

Authors:  P Narcisi; A J Richards; S D Ferguson; F M Pope
Journal:  Hum Mol Genet       Date:  1994-09       Impact factor: 6.150

View more
  7 in total

Review 1.  Elastic fibers in orthopedics: Form and function in tendons and ligaments, clinical implications, and future directions.

Authors:  Jeffrey Ryan Hill; Jeremy D Eekhoff; Robert H Brophy; Spencer P Lake
Journal:  J Orthop Res       Date:  2020-04-28       Impact factor: 3.494

2.  Generalized joint hypermobility does not influence clinical outcomes following isolated MPFL reconstruction for patellofemoral instability.

Authors:  Laurie Anne Hiemstra; Sarah Kerslake; Nathalie Kupfer; Mark R Lafave
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2019-03-27       Impact factor: 4.342

Review 3.  Mechanobiology in the Comorbidities of Ehlers Danlos Syndrome.

Authors:  Shaina P Royer; Sangyoon J Han
Journal:  Front Cell Dev Biol       Date:  2022-04-25

4.  Histopathological and electron microscopic study in dogs with patellar luxation and skin hyperextensibility.

Authors:  Kazunori Ueda; Tomoyuki Kawai; Haruki Senoo; Atsushi Shimizu; Akira Ishiko; Masahiko Nagata
Journal:  J Vet Med Sci       Date:  2018-07-06       Impact factor: 1.267

Review 5.  The Role of Cell Adhesion and Cytoskeleton Dynamics in the Pathogenesis of the Ehlers-Danlos Syndromes and Hypermobility Spectrum Disorders.

Authors:  Sabeeha Malek; Darius V Köster
Journal:  Front Cell Dev Biol       Date:  2021-04-21

Review 6.  Hypermobile Ehlers-Danlos syndromes: Complex phenotypes, challenging diagnoses, and poorly understood causes.

Authors:  Cortney Gensemer; Randall Burks; Steven Kautz; Daniel P Judge; Mark Lavallee; Russell A Norris
Journal:  Dev Dyn       Date:  2020-08-17       Impact factor: 3.780

7.  Ehlers-danlos syndrome-hypermobility type and hemorrhoids.

Authors:  Timothy P Plackett; Edward Kwon; Ronald A Gagliano; Robert C Oh
Journal:  Case Rep Surg       Date:  2014-04-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.